Atlas Trials

A Study to Evaluate the Efficacy and Safety of SIM0718 in Adult and Adolescent Patients With Moderate to Severe Atopic Dermatitis

Clinical trial NCT06477835 · COMPLETED

Trial details

NCT number
NCT06477835
Sponsor
Simcere Pharmaceutical Co., Ltd
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Atopic Dermatitis
Start date
2024-07-04
Primary completion
2025-11-04
Enrollment
259

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.